MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Natera, Inc. - Common Stock (NQ:NTRA)

207.19 -7.45 (-3.47%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 15, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,379,261
Open 217.62
Bid (Size) 205.00 (300)
Ask (Size) 214.70 (100)
Prev. Close 214.64
Today's Range 206.26 - 219.47
52wk Range 131.81 - 256.36
Shares Outstanding 139,693,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
1 Cash-Producing Stock to Own for Decades and 2 That Underwhelm
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it eff... 
Via StockStory
News headline image
Natera Highlights Positive Interim Futility Analysis from Allogene Therapeutics’ MRD-Guided ALPHA3 Trial in Large B-Cell Lymphoma
From Natera, Inc.
Via Business Wire

Performance

YTD
-9.5%
-9.5%
1 Month
+4.8%
+4.8%
3 Month
-12.9%
-12.9%
6 Month
+19.9%
+19.9%
1 Year
+39.6%
+39.6%

More News

Read More
News headline image
1 of Wall Street’s Favorite Stock with Exciting Potential and 2 We Find Risky
Via StockStory
News headline image
3 Reasons NTRA Has Explosive Upside Potential
Via StockStory
Natera Inc. (NASDAQ:NTRA) Crushes Q4 Earnings Estimates with Strong Oncology Growth ↗
Via Chartmill
News headline image
20 Abstracts at AACR Highlight Scale, Innovation and Clinical Impact of Natera’s Oncology Platform
From Natera, Inc.
Via Business Wire
News headline image
SignateraTM MRD Identifies Breast Cancer Patients Who Can Forgo Surgery
From Natera, Inc.
Via Business Wire
News headline image
Elanco, Tandem Diabetes, Fortrea, Natera, and Myriad Genetics Shares Plummet, What You Need To Know
Via StockStory
Topics Government Stocks
News headline image
Abbott Laboratories Finalizes $21 Billion Acquisition of Exact Sciences, Redefining the Future of Cancer Diagnostics
Via MarketMinute
Topics Supply Chain
News headline image
1 Unprofitable Stock to Own for Decades and 2 Facing Headwinds
Via StockStory
News headline image
1 Cash-Heavy Stock to Target This Week and 2 We Question
Via StockStory
News headline image
NeoGenomics, Natera, and Amphastar Pharmaceuticals Shares Skyrocket, What You Need To Know
Via StockStory
Topics Economy Stocks
News headline image
This Biotech Stock Surged 75% Last Quarter and Pulled a New $9 Million Investment ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
This Life Sciences Supplier Has Plunged 50% in a Year, but One Fund Bought Up $28 Million More in Stock ↗
Via The Motley Fool
Topics Regulatory Compliance Supply Chain
News headline image
Two Publications Highlight Clinical Utility of Signatera™ in Anal and Rectal Cancers
From Natera, Inc.
Via Business Wire
News headline image
3 Growth Stocks to Add to Your Roster
Via StockStory
News headline image
3 Market-Beating Stocks to Target This Week
Via StockStory
News headline image
Natera Announces Commercial Launch of Zenith™ Genomics for Rare Disease Diagnosis
From Natera, Inc.
Via Business Wire
News headline image
3 Healthcare Stocks to Target This Week
Via StockStory
News headline image
Natera (NTRA) Stock Trades Up, Here Is Why
Via StockStory
Topics Economy
News headline image
3 Reasons Exelixis Stock Could Deliver Market‑Beating Returns Over the Next Decade ↗
Via The Motley Fool
Topics Lawsuit
News headline image
Why Natera (NTRA) Shares Are Falling Today
Via StockStory
Topics Earnings Economy
News headline image
Signatera™ MRD Data at ASCO GU Highlights Potential Utility Across GU Cancers, Including for Bladder Preservation
From Natera, Inc.
Via Business Wire
News headline image
Natera (NTRA) Q4 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
Natera Reports Fourth Quarter and Full Year 2025 Financial Results
From Natera, Inc.
Via Business Wire

Frequently Asked Questions

Is Natera, Inc. - Common Stock publicly traded?
Yes, Natera, Inc. - Common Stock is publicly traded.
What exchange does Natera, Inc. - Common Stock trade on?
Natera, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Natera, Inc. - Common Stock?
The ticker symbol for Natera, Inc. - Common Stock is NTRA on the Nasdaq Stock Market
What is the current price of Natera, Inc. - Common Stock?
The current price of Natera, Inc. - Common Stock is 207.19
When was Natera, Inc. - Common Stock last traded?
The last trade of Natera, Inc. - Common Stock was at 04/15/26 04:00 PM ET
What is the market capitalization of Natera, Inc. - Common Stock?
The market capitalization of Natera, Inc. - Common Stock is 28.94B
How many shares of Natera, Inc. - Common Stock are outstanding?
Natera, Inc. - Common Stock has 29B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story